Literature DB >> 2171207

Vaccinia virus host range genes.

M E Perkus1, S J Goebel, S W Davis, G P Johnson, K Limbach, E K Norton, E Paoletti.   

Abstract

A gene encoding an 18-kDa polypeptide (ORF C7L) located in the vaccinia virus HindIII C fragment was shown to be functionally equivalent to previously described host range gene (ORF K1L) spanning the HindIII K/M fragment junction. Either C7L or K1L host range gene is necessary and sufficient by itself to allow replication of vaccinia virus on human cells. Deletion of both C7L and K1L genes from the wild-type vaccinia genome is required to derive a virus deficient for replication on human cells. Further, an ORF encoding a 77-kDa polypeptide derived from cowpox (CP77kDa) and previously shown to allow vaccinia to overcome the restriction for replication on Chinese hamster ovary cells could substitute for the vaccinia host range genes C7L and K1L in permitting replication of the virus on human cells. Additionally, the three unique host range genes C7L, K1L, and CP77kDa were functionally equivalent for vaccinia replication on pig kidney cells, but not on rabbit kidney cells.

Entities:  

Mesh:

Substances:

Year:  1990        PMID: 2171207     DOI: 10.1016/0042-6822(90)90296-4

Source DB:  PubMed          Journal:  Virology        ISSN: 0042-6822            Impact factor:   3.616


  81 in total

1.  Genome-wide analysis of vaccinia virus protein-protein interactions.

Authors:  S McCraith; T Holtzman; B Moss; S Fields
Journal:  Proc Natl Acad Sci U S A       Date:  2000-04-25       Impact factor: 11.205

2.  Viral double-stranded RNAs from vaccinia virus early or intermediate gene transcripts possess PKR activating function, resulting in NF-kappaB activation, when the K1 protein is absent or mutated.

Authors:  Kristen L Willis; Jeffrey O Langland; Joanna L Shisler
Journal:  J Biol Chem       Date:  2010-12-23       Impact factor: 5.157

3.  Genome of horsepox virus.

Authors:  E R Tulman; G Delhon; C L Afonso; Z Lu; L Zsak; N T Sandybaev; U Z Kerembekova; V L Zaitsev; G F Kutish; D L Rock
Journal:  J Virol       Date:  2006-09       Impact factor: 5.103

4.  Cellular and biochemical differences between two attenuated poxvirus vaccine candidates (MVA and NYVAC) and role of the C7L gene.

Authors:  José Luis Nájera; Carmen Elena Gómez; Elena Domingo-Gil; María Magdalena Gherardi; Mariano Esteban
Journal:  J Virol       Date:  2006-06       Impact factor: 5.103

5.  Host response to the attenuated poxvirus vector NYVAC: upregulation of apoptotic genes and NF-kappaB-responsive genes in infected HeLa cells.

Authors:  Susana Guerra; Luis A López-Fernández; Alberto Pascual-Montano; José Luis Nájera; Angel Zaballos; Mariano Esteban
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

6.  Sequence and transcriptional analysis of an orf virus gene encoding ankyrin-like repeat sequences.

Authors:  J T Sullivan; K M Fraser; S B Fleming; A J Robinson; A A Mercer
Journal:  Virus Genes       Date:  1995-02       Impact factor: 2.332

7.  Structure function studies of vaccinia virus host range protein k1 reveal a novel functional surface for ankyrin repeat proteins.

Authors:  Yongchao Li; Xiangzhi Meng; Yan Xiang; Junpeng Deng
Journal:  J Virol       Date:  2010-01-20       Impact factor: 5.103

8.  Vaccinia Virus Encodes a Novel Inhibitor of Apoptosis That Associates with the Apoptosome.

Authors:  Melissa R Ryerson; Monique M Richards; Marc Kvansakul; Christine J Hawkins; Joanna L Shisler
Journal:  J Virol       Date:  2017-11-14       Impact factor: 5.103

9.  Structural basis for antagonizing a host restriction factor by C7 family of poxvirus host-range proteins.

Authors:  Xiangzhi Meng; Brian Krumm; Yongchao Li; Junpeng Deng; Yan Xiang
Journal:  Proc Natl Acad Sci U S A       Date:  2015-11-17       Impact factor: 11.205

10.  Stable expression of the vaccinia virus K1L gene in rabbit cells complements the host range defect of a vaccinia virus mutant.

Authors:  G Sutter; A Ramsey-Ewing; R Rosales; B Moss
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.